Burning Rock Biotech Limited logo
Burning Rock Biotech Limited BNR
$ 22.99 -2.36%

Annual report 2021
added 12-23-2023

report update icon

Burning Rock Biotech Limited Balance Sheet 2011-2026 | BNR

Annual Balance Sheet Burning Rock Biotech Limited

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - -76 M -7.69 M - - - - - - -

Long Term Debt

- - 18.3 M 87.6 M - - - - - - -

Total Non Current Liabilities

61.1 M 491 K 47.6 M 691 M - - - - - - -

Total Current Liabilities

372 M 242 M 164 M - - - - - - - -

Total Liabilities

433 M 242 M 212 M 976 M - - - - - - -

Deferred Revenue

143 M 74.4 M 49.5 M 58 M - - - - - - -

Retained Earnings

-2.23 B -1.42 B -946 M -612 M - - - - - - -

Total Assets

2.28 B 2.66 B 848 M 373 M - - - - - - -

Cash and Cash Equivalents

- 1.9 B 94.2 M 95.3 M - - - - - - -

Book Value

1.85 B 2.42 B 636 M -603 M - - - - - - -

Total Shareholders Equity

1.85 B 2.42 B -891 M -603 M - - - - - - -

All numbers in CNY currency

Quarterly Balance Sheet Burning Rock Biotech Limited

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - 49.3 M - - - - - - - 18.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - 61.1 M - - - 491 K - - - 47.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - 433 M - - - 242 M - - - 212 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - 143 M - - - 74.4 M - - - 49.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - - - -2.23 B - - - -1.42 B - - - -946 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - - - 2.28 B - - - 2.66 B - - - 848 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - - - 1.43 B - - - 1.9 B - - - 94.2 M - - - 93.3 M - - - 54.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

- - - - 1.85 B - - - 2.42 B - - - 636 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - - - 1.85 B - - - 2.42 B - - - -891 M - - - -603 M - - - -372 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in CNY currency

Balance Sheet is a fundamental financial report of Burning Rock Biotech Limited, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Diagnostics research

Issuer Price % 24h Market Cap Country
Anixa Biosciences Anixa Biosciences
ANIX
$ 2.91 2.83 % $ 94.4 K usaUSA
Agilent Technologies Agilent Technologies
A
$ 120.6 1.35 % $ 36.7 B usaUSA
Centogene N.V. Centogene N.V.
CNTG
- -6.23 % $ 30.6 M germanyGermany
Aspira Women's Health Aspira Women's Health
AWH
- -6.19 % $ 10.5 M usaUSA
Castle Biosciences Castle Biosciences
CSTL
$ 28.29 2.59 % $ 786 M usaUSA
Celcuity Celcuity
CELC
$ 110.26 2.66 % $ 4.35 B usaUSA
Akumin Akumin
AKU
- -17.87 % $ 25.9 M canadaCanada
Fulgent Genetics Fulgent Genetics
FLGT
$ 14.17 2.76 % $ 428 M usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
- - $ 562 M britainBritain
Heska Corporation Heska Corporation
HSKA
- - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
- -20.0 % $ 1.06 M usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
$ 179.36 2.09 % $ 8.89 B usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
- -61.36 % $ 2.46 M usaUSA
IDEXX Laboratories IDEXX Laboratories
IDXX
$ 645.0 1.49 % $ 51.9 B usaUSA
Illumina Illumina
ILMN
$ 130.32 0.59 % $ 20.7 B usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
- - $ 399 M chinaChina
Fluidigm Corporation Fluidigm Corporation
FLDM
- 1.08 % $ 308 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
- - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
- 0.12 % $ 80.1 M chinaChina
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
$ 281.71 -0.48 % $ 23.4 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
$ 77.76 -1.37 % $ 5.25 B usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
- - $ 10.7 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
- -34.28 % $ 263 K israelIsrael
Biodesix Biodesix
BDSX
$ 15.22 -1.81 % $ 1.97 B usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
$ 1 301.87 -1.13 % $ 26.8 B schweizSchweiz
Biocept Biocept
BIOC
- -13.05 % $ 7.29 M usaUSA
Myriad Genetics Myriad Genetics
MYGN
$ 5.37 1.51 % $ 497 M usaUSA
NeoGenomics NeoGenomics
NEO
$ 9.28 -2.73 % $ 1.19 B usaUSA
Invitae Corporation Invitae Corporation
NVTA
- - $ 21.2 M usaUSA
National Research Corporation National Research Corporation
NRC
$ 13.21 -1.34 % $ 324 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
$ 1.14 2.0 % $ 1.45 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
$ 208.57 0.1 % $ 23.2 B usaUSA
Danaher Corporation Danaher Corporation
DHR
$ 204.44 0.21 % $ 146 B usaUSA
Organovo Holdings Organovo Holdings
ONVO
- -2.3 % $ 19.4 M usaUSA
OPKO Health OPKO Health
OPK
$ 1.2 0.84 % $ 833 M usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
$ 103.47 0.09 % $ 19.5 B usaUSA
Bioventus Bioventus
BVS
$ 8.56 -2.06 % $ 536 M usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
$ 1.59 4.56 % $ 477 M usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
$ 9.67 -6.12 % $ 274 M israelIsrael
DexCom DexCom
DXCM
$ 73.24 0.22 % $ 28.6 B usaUSA
PerkinElmer PerkinElmer
PKI
- -0.91 % $ 14.7 B usaUSA
Psychemedics Corporation Psychemedics Corporation
PMD
- -1.84 % $ 15.3 M usaUSA
Precipio Precipio
PRPO
$ 26.37 5.57 % $ 34.2 M usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
- - $ 10.6 B niderlandNiderland
Personalis Personalis
PSNL
$ 8.79 1.38 % $ 521 M usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
$ 109.93 1.13 % $ 9.07 B irlandaIrlanda
Quotient Limited Quotient Limited
QTNT
- -11.32 % $ 1.1 M schweizSchweiz
Renalytix AI plc Renalytix AI plc
RNLX
- 5.66 % $ 22.7 M britainBritain
CareDx, Inc CareDx, Inc
CDNA
$ 19.25 2.39 % $ 1.03 B usaUSA